AltData’s MedTech AI Platform empowers healthcare innovators, device manufacturers, and clinical researchers to accelerate product development and validation using synthetic data generation, medical image analytics, and on-device AI deployment.
Selected under the “CSIRO Innovate to Grow – Health Care Innovation Program“, and in collaboration with Sascan Meditech, AltData is developing Cervi-Lite, a portable, smartphone-based fluorescence imaging and photodynamic therapy (PDT) system for real-time detection and treatment of cervical pre-cancers.
This platform exemplifies our mission: to democratize clinical AI development through secure, privacy-preserving data technologies that drive faster R&D and improve health outcomes.
Why Synthetic Data for MedTech?
Healthcare innovation is constrained by data scarcity, privacy barriers, and regulatory requirements. Synthetic data generation provides a safe, reproducible path to model development, enabling training, testing, and validation without relying on sensitive patient data.
- Medical imaging modalities: fluorescence, endoscopy, ultrasound, dermoscopy, radiology
- Sensor & device telemetry: time-series generation for physiological and device data
- Clinical data fusion: integrating electronic health records, imaging, and lab metrics
- Privacy-preserving learning: synthetic datasets ensure GDPR, HIPAA, and OAIC compliance
Cervi-Lite: AI-Powered Cervical Cancer Detection & Treatment
Cervi-Lite is AltData’s flagship MedTech innovation, an integrated diagnostic and treatment system co-developed with Sascan Meditech under the CSIRO Innovate to Grow Program.
Key Features
- AI + Fluorescence Imaging: Real-time detection of pre-cancerous lesions (CIN I–II)
- On-Device Cancer Grading: Embedded ML models for immediate risk prediction
- Photodynamic Therapy (PDT): Non-invasive, fertility-preserving treatment
- Cloud Integration: Secure upload for QA, learning, and remote specialist audit
- Field Deployable: Affordable, reusable design for outreach and rural clinics
Clinical Impact
- Reduces referral dropout and diagnostic delay
- Empowers regional practitioners with AI decision support
- Aligns with National Cervical Screening Program (NCSP)
- Improves equity for Indigenous and underserved women
AI and Data Capabilities
- Synthetic data pipelines for pre-training and augmentation
- Automated labeling and annotation for fluorescence and cytology images
- Model development frameworks (classification, segmentation, anomaly detection)
- Explainable AI (XAI) for regulatory transparency
- Cloud-to-edge deployment for mobile inference
Key Advantages
| Capability | Benefit |
|---|---|
| Synthetic data generation | Enables R&D without patient-identifiable data |
| On-device AI | Real-time decision support in the field |
| Integrated therapy (PDT) | One-stop detection and treatment |
| Scalable hardware | Optimized for outreach and low-resource settings |
| Cloud learning platform | Continuous improvement and remote oversight |
| Regulatory-ready workflows | Supports TGA/FDA/CE compliance |
Collaboration & R&D Opportunities
Through the Innovate to Grow program, AltData and Sascan are co-developing pilot studies, model validation frameworks, and cloud-integrated analytics for clinical rollout in 2026.
- Healthcare providers: pilot deployment with regional & Indigenous clinics
- Research institutions: dataset generation and validation
- Device manufacturers: embedding AI into optical or biosensing hardware
- Government and grant partners: scaling equitable access to diagnostics
Get Involved
AltData’s MedTech team is actively seeking partnerships for clinical validation, device integration, and co-development under national innovation initiatives.